{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:37:38Z","timestamp":1791823058766,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cgh.2025.05.016","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T12:05:17Z","timestamp":1749816317000},"page":"606-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacological Strategies for the Management of Severe Alcohol-associated Hepatitis: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"24","author":[{"given":"Alvi H.","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Alvizuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailemichael","family":"Desalegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Idalsoaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Antonio","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene Y.","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani K.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Jairath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Qasim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-396X","authenticated-orcid":false,"given":"Juan Pablo","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2025.05.016_bib1","article-title":"Rising alcohol-associated liver disease-related mortality rates in the United States from 1999 to 2022","volume":"7","author":"Ilyas","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2025.05.016_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.05.016_bib3","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMra2207599","article-title":"Alcohol-associated hepatitis","volume":"387","author":"Bataller","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2025.05.016_bib4","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1111\/liv.15701","article-title":"Management of alcoholic hepatitis: a clinical perspective","volume":"43","author":"Kasper","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2025.05.016_bib5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/apt.18159","article-title":"Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - results from the HRS Harmony Consortium","volume":"60","author":"Ma","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2025.05.016_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/j.gastro.2023.11.306","article-title":"Hepatorenal syndrome in cirrhosis","volume":"166","author":"Pose","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.05.016_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jceh.2023.01.018","article-title":"Acute kidney injury in alcohol-associated hepatitis: more than a bystander","volume":"13","author":"Howarth","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.cgh.2025.05.016_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhep.2018.10.023","article-title":"Inflammatory pathways in alcoholic steatohepatitis","volume":"70","author":"Gao","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2025.05.016_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2025.05.016_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.14309\/ajg.0000000000002275","article-title":"Safety, pharmacokinetics, and efficacy signals of larsucosterol (DUR-928) in alcohol-associated hepatitis","volume":"119","author":"Hassanein","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.05.016_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12072-022-10438-0","article-title":"Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial","volume":"17","author":"Pande","year":"2023","journal-title":"Hepatology Int"},{"key":"10.1016\/j.cgh.2025.05.016_bib12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jhep.2024.01.031","article-title":"Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis","volume":"80","author":"Gawrieh","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2025.05.016_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.14309\/ajg.0000000000003038","article-title":"Granulocyte colony stimulating factor improves prednisolone responsiveness and 90-day survival in steroid eligible severe alcohol associated hepatitis: the GPreAH Study a randomized trial","volume":"120","author":"Mishra","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.05.016_bib14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL Clinical Practice Guidelines: management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2025.05.016_bib15","article-title":"Safety and efficacy of infliximab in severe alcoholic hepatitis: a systematic review","volume":"11","author":"Majeed","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.cgh.2025.05.016_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.coph.2021.06.011","article-title":"Treatment of severe alcoholic hepatitis: a systematic review","volume":"60","author":"Van Melkebeke","year":"2021","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.cgh.2025.05.016_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/17474124.2014.903800","article-title":"Prognosis and treatment of patients with acute alcoholic hepatitis","volume":"8","author":"Papastergiou","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.05.016_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.14309\/ajg.0000000000001596","article-title":"The MELD score is superior to the Maddrey Discriminant Function score to predict short-term mortality in alcohol-associated hepatitis: a global study","volume":"117","author":"Morales-Arr\u00e1ez","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.05.016_bib19","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2021.06.019","article-title":"Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study","volume":"75","author":"Arab","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2025.05.016_bib20","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2025.05.016_bib21","first-page":"178","article-title":"Current management and future treatment of alcoholic hepatitis","volume":"16","author":"Mitchell","year":"2020","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.cgh.2025.05.016_bib22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cgh.2025.05.016_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2025.05.016_bib25","author":"Buchan"},{"key":"10.1016\/j.cgh.2025.05.016_bib26","series-title":"The BGLIMM Procedure. SAS\/STAT 151 User\u2019s Guide","year":"2018"},{"key":"10.1016\/j.cgh.2025.05.016_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2025.05.016_bib28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2025.05.016_bib29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: a systematic review and network meta-analysis","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.05.016_bib30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/HEP.0000000000000645","article-title":"New insights into the molecular basis of alcohol abstinence and relapse in alcohol-associated liver disease","volume":"82","author":"Diaz","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2025.05.016_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000573","article-title":"Comparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitis","volume":"8","author":"Islam","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2025.05.016_bib32","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.05.016_bib33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MCG.0000000000000674","article-title":"Treatment of severe alcoholic hepatitis with corticosteroid, pentoxifylline, or dual therapy: a systematic review and meta-analysis","volume":"51","author":"Lee","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2025.05.016_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/SLA.0b013e3181f4e479","article-title":"Stem cell mobilization is life saving in an animal model of acute liver failure","volume":"252","author":"Mark","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.cgh.2025.05.016_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/00952990.2024.2308789","article-title":"Granulocyte-colony stimulating factor use in alcohol-associated hepatitis: is it time to promote liver regeneration?","volume":"50","author":"D\u00edaz","year":"2024","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.cgh.2025.05.016_bib36","article-title":"Granulocyte colony-stimulating factor for alcoholic hepatitis: a systematic review and meta-analysis of randomised controlled trials","volume":"2","author":"Marot","year":"2020","journal-title":"JHEP Rep"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525004938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525004938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T07:17:46Z","timestamp":1779607066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356525004938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1542356525004938"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2025.05.016","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Strategies for the Management of Severe Alcohol-associated Hepatitis: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2025.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the AGA Institute","name":"copyright","label":"Copyright"}]}}